De la Cruz Antonio, Teufert Karen B
House Ear Institute, Los Angeles, California, USA.
Otol Neurotol. 2009 Apr;30(3):373-80. doi: 10.1097/MAO.0b013e31819a892b.
Evaluate transcochlear (TC)/transotic (TO) approaches surgery for midline intradural lesions arising from the clivus and cerebellopontine angle masses arising anterior to the internal auditory canal.
Retrospective chart review.
Tertiary referral neurotologic practice.
PATIENTS/INTERVENTION: Forty patients who underwent TC/TO approach surgery. Patients were grouped by whether the facial nerve was mobilized (TC, n = 15) or not (TO, n = 25).
Indications, postoperative outcomes, and complications including tumor removal and facial nerve status (House-Brackmann grade).
Forty percent of all TC patients were meningiomas, whereas 36% of all TO patients were cochlear neuromas. The remainder included tumors associated with NF2, acoustic tumors, malignancies, and other lesions. Complete removal was achieved in 92.5% of tumors. Of all patients, 42% and 55% had normal facial nerve function at the time of hospital discharge and follow up, respectively. Moreover, 22% underwent a facial nerve reanastomosis procedure. Early and late complications occurred in 11 and 14%, respectively. There was one surgery-related death. Complications included cerebrospinal fluid leak (9%) and unsteadiness (9%).
The TC and TO approaches provide access to midline intradural lesions, intradural petroclival tumors, and cerebellopontine angle tumors and cholesteatomas arising anterior to the internal auditory canal, without using brain retractors. Total tumor removal, including its base and blood supply, is possible. Facial weakness is frequent when the facial nerve is rerouted, but excellent facial nerve results are accomplished with the TO approach. With these approaches, recurrence israre when all tumor has been removed. Their safety and efficacy encourage their use in extensive lesions.
评估经耳蜗(TC)/经耳(TO)入路手术治疗起源于斜坡的中线硬膜内病变以及起源于内耳道前方的桥小脑角肿物。
回顾性病历审查。
三级转诊神经耳科诊所。
患者/干预措施:40例行TC/TO入路手术的患者。根据面神经是否被游离分为两组(TC组,n = 15;TO组,n = 25)。
手术适应证、术后结果及并发症,包括肿瘤切除情况及面神经状态(House - Brackmann分级)。
所有TC组患者中40%为脑膜瘤,而所有TO组患者中36%为耳蜗神经瘤。其余包括与神经纤维瘤病2型(NF2)相关的肿瘤、听神经瘤、恶性肿瘤及其他病变。92.5%的肿瘤实现了完全切除。所有患者中,分别有42%和55%在出院时及随访时面神经功能正常。此外,22%的患者接受了面神经再吻合手术。早期和晚期并发症发生率分别为11%和14%。有1例与手术相关的死亡。并发症包括脑脊液漏(9%)和步态不稳(9%)。
TC和TO入路可用于治疗中线硬膜内病变、硬膜内岩斜区肿瘤、桥小脑角肿瘤以及起源于内耳道前方的胆脂瘤,无需使用脑牵开器。可以完整切除肿瘤,包括其基底和血供。当面神经改道时面神经麻痹很常见,但TO入路可取得出色的面神经功能结果。采用这些入路,当所有肿瘤均被切除时复发罕见。其安全性和有效性促使其可用于广泛病变。